Skip to main content
Find more clinical trials

Diabetes Management for African Americans With Mild Cognitive Impairment

Start: October 25, 2021
End: January 31, 2025
Enrollment: 200

What Is This Study About?

This study will explore whether a behavioral treatment program for people with diabetes, called DREAM, can improve memory for African Americans with both poorly controlled diabetes and mild cognitive impairment (MCI). Participants will be randomly assigned to complete the DREAM program or a different home-based diabetes education. Over two years, all participants will have 11 in-home visits with a community health worker who will provide information on diabetes management. Participants in the DREAM program group will also receive four telehealth visits with a diabetes nurse educator. Every six months, all participants will complete memory tests, give blood, and undergo an eye exam. Researchers will use results from these tests to evaluate any changes in cognitive impairment and diabetes management.

Do I Qualify To Participate in This Study?

Minimum Age: 65 Years

Maximum Age: N/A

Must have:

  • African American or Black ancestry
  • Diagnosis of MCI
  • Type 2 diabetes for at least one year before starting study, with:
    • Blood A1C > 7.5

Must NOT have:

  • Diagnosis of dementia
  • Any medical illness or condition that could interfere with the study
  • Any serious psychiatric disorder that could interfere with the study
  • Life expectancy less than two years

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 
Study Contact
Robin Casten, PhD
Megan Kelley

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Pennsylvania
Thomas Jefferson University
Philadelphia, PA 19107
Recruiting
Robin J Casten, PhD

Who Sponsors This Study?

Lead: Thomas Jefferson University

Source: ClinicalTrials.gov ID: NCT04259047